In contrast, while short-acting GLP-1 RAs did not show significant effects on MAKE in our cohort, it is important to note that lixisenatide has shown kidney benefits in the ELIXA trial 32
Our care team provides ongoing support and regular follow-ups to track your progress and adjust treatments
The standard escalation schedule introduces the medication in small increments: Week 14 you receive 0.25 mg, Week 58 you move to 0.5 mg, Week 912 you reach 1 mg, and Week 1316 you advance to 1.7 mg before reaching the maintenance dose of 2.4 mg weekly
The Alba and Nexa Syringe Platforms The combination of Alba and Nexa syringes with SHL Medicals autoinjector technology provides a robust solution for sensitive biologics
But the point of the medication is not to starve and never feel hungry again
Your dietitian will work with you to ensure adequate protein and nutrient intake despite potentially reduced appetite, and may adjust your supplementation regimen accordingly